Frederic H. Moll - Feb 21, 2024 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Role
Director
Signature
/s/ Wade Estey, as attorney-in-fact for Frederic H. Moll
Stock symbol
SWAV
Transactions as of
Feb 21, 2024
Transactions value $
-$15,443,412
Form type
4
Date filed
2/22/2024, 08:15 PM
Previous filing
Feb 9, 2024
Next filing
May 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale -$1.64M -6.44K -1.85% $255.14 341K Feb 21, 2024 Direct F1
transaction SWAV Common Stock Sale -$4.21M -16.5K -4.83% $255.95 325K Feb 21, 2024 Direct F2
transaction SWAV Common Stock Sale -$3.64M -14.2K -4.36% $256.82 310K Feb 21, 2024 Direct F3
transaction SWAV Common Stock Sale -$2.23M -8.65K -2.79% $258.09 302K Feb 21, 2024 Direct F4
transaction SWAV Common Stock Sale -$689K -2.66K -0.88% $258.95 299K Feb 21, 2024 Direct F5
transaction SWAV Common Stock Sale -$1.44M -5.53K -1.85% $259.91 294K Feb 21, 2024 Direct F6
transaction SWAV Common Stock Sale -$1.28M -4.89K -1.67% $260.80 289K Feb 21, 2024 Direct F7
transaction SWAV Common Stock Sale -$314K -1.2K -0.42% $261.96 288K Feb 21, 2024 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $254.43 to $255.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $255.43 to $256.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $256.43 to $257.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $257.43 to $258.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $258.43 to $259.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $259.44 to $260.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $260.45 to $261.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F8 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $261.54 to $262.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.